Ovarian Cancer Resource Center: Featured Article

Article

 

Ovarian Cancer: Is it Time for Personalized Approaches? 

 Ovarian cancer kills roughly 16,000 women each year. While the disease has traditionally been treated with surgery and chemotherapy, new targeted therapies show promise. This week our authors discuss and debate the

new treatment

approaches

, including the merits of

personalized medicine

.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content